Goldman Sachs
ZLAB icon

Goldman Sachs’s Zai Lab ZLAB Stock Holding History

Goldman Sachs’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,800
Closed -$643K – 6489
2025
Q1 		$643K Buy
+17,800
New +$548K ﹤0.01% 5028
2020
Q2 		– Sell
-15,000
Closed -$772K – 5522
2020
Q1 		$772K Buy
+15,000
New +$782K ﹤0.01% 3930

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Goldman Sachs's ZLAB Position: Q2 2026 in Review

Goldman Sachs increased its Zai Lab (ZLAB) stake by 1,994% in Q2 2026, buying an estimated $43.6M and bringing the position to 2,315,480 shares worth $44M. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

Goldman Sachs first reported a position in ZLAB in Q3 2017 and has held it in 33 quarters since. The position peaked at $87.8M in Q3 2020. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Goldman Sachs held 2,315,480 shares of Zai Lab worth $44M as of Q2 2026.
  • Goldman Sachs bought 2,204,893 Zai Lab shares in Q2 2026, an estimated $43.6M.
  • Zai Lab made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #1923 holding.
  • Goldman Sachs first reported a position in Zai Lab in Q3 2017 and has held it in 33 quarters since.
  • Goldman Sachs's Zai Lab position peaked at $87.8M in Q3 2020.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.